AC
Therapeutic Areas
Cognition Therapeutics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| CT1812 | Mild-to-Moderate Alzheimer's Disease | Phase 2 |
Leadership Team at Cognition Therapeutics
LR
Lisa Ricciardi
President and Chief Executive Officer
KI
Kenneth I. Moch
Chairman of the Board
JM
Jeffrey M. Dayno
Director